Comparison of salivary cortisol level in patients with controlled type II diabetes and healthy subjects

Authors

Masoomeh Shirzaii, A Nakhaee,*, V Moradi
*Corresponding Author: Email: [email protected]

Journal of Inflammatory Diseases:Vol. 20, issue 2; 40-34
Published online:Jul 13, 2016
Article type:Research Article
How to Cite:Shirzaii M, Nakhaee A, Moradi V. Comparison of salivary cortisol level in patients with controlled type II diabetes and healthy subjects. J Inflamm Dis. 2024;20(2):e155961. doi:

Abstract

Background: Salivary gland dysfunction has commonly been mentioned by patients with diabetes. Objective: The aim of this study was to compare the salivary cortisol level between patients with controlled type 2 diabetes and healthy subjects. Methods: In this case-control study (2014-15), the unstimulated salivary samples were collected from 60 patients with controlled type 2 diabetes above 30 years old (case group) and 60 healthy subjects (control group) matched for age and gender. The samples were transferred to the laboratory and salivary cortisol levels were measured using ELIZA. Data were analyzed using independent sample T-Test. Findings: The mean salivary cortisol level in patients with type 2 diabetes (1.73±1.017 mmol/ dL) was significantly different from healthy controls (1.08±0.643 mmol/ dL). The mean salivary cortisol levels in men (1.73±1.05 mmol/ dL) and women (1.73±1.01 mmol/ dL) with type 2 diabetes were significantly higher than healthy men (0.74±0.44 mmol/ dL) and women (1.26±0.66 mmol/ dL). Conclusion: With regards to the results, it seems that salivary cortisol level considerably increases in patients with controlled type 2 diabetes in comparison with healthy subjects.  

Copyright

© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

9
Apr
2012

Evaluation Chemical Composition of Unstimulated Saliva, in Patients with Type I Diabetes Mellitus

Masoomeh Shirzaii,
Fathemeh Heidari

Shirzaii M, Heidari F. Evaluation Chemical Composition of Unstimulated Saliva, in Patients with Type I Diabetes Mellitus. Zahedan J Res Med Sci. 2013;15(1):e93134. doi:

25
Jun
2017
Stimulated and Unstimulated Saliva Glucose Levels in Children Suffer Insulin-Dependent Diabetes Mellitus

Stimulated and Unstimulated Saliva Glucose Levels in Children Suffer Insulin-Dependent Diabetes Mellitus

Mina Khayamzdeh,
Iraj Mirzaii-Dizgah,
Parastoo Rostami,
Farimah Izadi,
Marjan Khayamzadeh,
Mohammad-Javad Kharazifard

Khayamzdeh M, Mirzaii-Dizgah I, Rostami P, Izadi F, Khayamzadeh M, et al. Stimulated and Unstimulated Saliva Glucose Levels in Children Suffer Insulin-Dependent Diabetes Mellitus. Ann Mil Health Sci Res. 2017;15(2):e64373. doi: https://doi.org/10.5812/amh.64373

30
Jun
2003

‌patients dependent diabetes - insulin - Salivary alterations in non

K Borhan Mojabi,
M Rasasnian

Borhan Mojabi K, Rasasnian M. ‌patients dependent diabetes - insulin - Salivary alterations in non. J Inflamm Dis. 2024;7(1):e154927. doi:

12
Oct
2013

Stimulated Saliva Glucose as a Diagnostic Specimen for Detection of Diabetes Mellitus

Iraj Mirzaii-Dizgah,
Mohammad-Reza Mirzaii-Dizgah,
Mohammad-Hossein Mirzaii-Dizgah

Mirzaii-Dizgah I, Mirzaii-Dizgah M, Mirzaii-Dizgah M. Stimulated Saliva Glucose as a Diagnostic Specimen for Detection of Diabetes Mellitus. J Arch Mil Med. 2013;1(1):24-27. doi: https://doi.org/10.5812/jamm.14609

1
Sep
2014

Serum Interleukin 17 in Type 2 Diabetes Mellitus

Parvin Zareian,
Iraj Mirzaii Dizgah

Zareian P, Mirzaii Dizgah I. Serum Interleukin 17 in Type 2 Diabetes Mellitus. J Arch Mil Med. 2014;2(4):e24689. doi: https://doi.org/10.5812/jamm.24689

More by these authors

Masoomeh ShirzaiiPubMedScholar
A NakhaeePubMedScholar
Share
Cited by
Metrics